Articles by The Wall Street Analyzer

About The Wall Street Analyzer
The Wall Street Analyzer's staff of writers, analysts, publishers, producers, market researchers, and PR professionals aim to provide investors with the tools they need to make informed decisions on buying stock. Our staff is a mix of financial professionals and media savvy individuals whose experiences bring the best talent from both ends of the spectrum.
No Picture
Healthcare

Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50

August 20, 2019 The Wall Street Analyzer Comments Off on Generex Announces Acquisition of Additional 38% of Subsidiary Olaregen Therapeutix in an Up-Market Transaction with a Share Exchange of GNBT Stock at $2.50

Generex  Now Owns 99% of Subsidiary Olaregen Therapeutix Generex Satisfies Notes for $138,000 and $900,000 to clear debt NuGenerex Immuno-Oncology Spin-out Evaluating Acquisition of a Hospital Network Completed Audit of Direct-to-Patient Pharmacy Business MIRAMAR, Fla., […]